IndieBio companies Sundial Foods, California Cultured, and Lypid talk about their innovations ahead of Demo Day.

Jim Collins, bioengineer, and Termeer Professor of Medical Engineering & Science and Professor of Biological Engineering at MIT. on "Designing Science" podcast with Arvind Gupta, Founder and Venture Advisor at IndieBio, Partner at Mayfield

IndieBio is a leading seed-stage life science accelerator program devoted to funding and building startups dedicated to solving humanity’s most pressing problems through biology.

We enable the best scientists to become entrepreneurs, and nurture the future leaders of movements and systemic change. Our technology focus is on reinventing the food and water supply chain, medicine, healthcare, diagnostics, agriculture, and biomaterial industries. To date, 116 companies have graduated from the program, with a combined current valuation of over $2B.

IndieBio is a member of SOSV a $700M global fund focused on lasting impact.

Alex Lorestani, CEO & Co-founder of Geltor featured on "Designing Science" podcast with Arvind Gupta, Founder and Managing director of IndieBio.

IndieBio is a leading seed-stage life science accelerator program devoted to funding and building startups dedicated to solving humanity’s most pressing problems through biology.

We enable the best scientists to become entrepreneurs, and nurture the future leaders of movements and systemic change. Our technology focus is on reinventing the food and water supply chain, medicine, healthcare, diagnostics, agriculture, and biomaterial industries. To date, 116 companies have graduated from the program, with a combined current valuation of over $2B.

IndieBio is a member of SOSV a $700M global fund focused on lasting impact.

Follow on www.twitter.com/indbio

Alex Lorestani, CEO & Co-founder of Geltor featured on "Designing Science" podcast with Arvind Gupta, Founder and Managing director of IndieBio.

IndieBio is a leading seed-stage life science accelerator program devoted to funding and building startups dedicated to solving humanity’s most pressing problems through biology.

We enable the best scientists to become entrepreneurs, and nurture the future leaders of movements and systemic change. Our technology focus is on reinventing the food and water supply chain, medicine, healthcare, diagnostics, agriculture, and biomaterial industries. To date, 116 companies have graduated from the program, with a combined current valuation of over $2B.

IndieBio is a member of SOSV a $700M global fund focused on lasting impact.

Follow on www.twitter.com/indbio

Calvin Nguyen, co-founder of BrainMind featured on "Designing Science" podcast with Arvind Gupta, Founder and Managing director of IndieBio.

IndieBio is a leading seed-stage life science accelerator program devoted to funding and building startups dedicated to solving humanity’s most pressing problems through biology.

We enable the best scientists to become entrepreneurs, and nurture the future leaders of movements and systemic change. Our technology focus is on reinventing the food and water supply chain, medicine, healthcare, diagnostics, agriculture, and biomaterial industries. To date, 116 companies have graduated from the program, with a combined current valuation of over $2B.

IndieBio is a member of SOSV a $700M global fund focused on lasting impact.

Follow on www.twitter.com/indbio

Jessica Briggs, UCSF Clinical Research Fellow in Infectious Diseases featured on "Designing Science" podcast with Arvind Gupta, Founder and Managing director of IndieBio.

IndieBio is a leading seed-stage life science accelerator program devoted to funding and building startups dedicated to solving humanity’s most pressing problems through biology.

We enable the best scientists to become entrepreneurs, and nurture the future leaders of movements and systemic change. Our technology focus is on reinventing the food and water supply chain, medicine, healthcare, diagnostics, agriculture, and biomaterial industries. To date, 116 companies have graduated from the program, with a combined current valuation of over $2B.

IndieBio is a member of SOSV a $700M global fund focused on lasting impact.

Follow on www.twitter.com/indbio

Vladimir Bulovic, Director of MIT.nano featured on "Designing Science" podcast with Arvind Gupta, Founder and Managing director of IndieBio.

IndieBio is a leading seed-stage life science accelerator program devoted to funding and building startups dedicated to solving humanity’s most pressing problems through biology.

We enable the best scientists to become entrepreneurs, and nurture the future leaders of movements and systemic change. Our technology focus is on reinventing the food and water supply chain, medicine, healthcare, diagnostics, agriculture, and biomaterial industries. To date, 116 companies have graduated from the program, with a combined current valuation of over $2B.

IndieBio is a member of SOSV a $700M global fund focused on lasting impact.

Follow on www.twitter.com/indbio

Emily Leproust, CEO of Twist Biosciences featured on "Designing Science" podcast with Arvind Gupta, Founder and Managing director of IndieBio.

IndieBio is a leading seed-stage life science accelerator program devoted to funding and building startups dedicated to solving humanity’s most pressing problems through biology.

We enable the best scientists to become entrepreneurs, and nurture the future leaders of movements and systemic change. Our technology focus is on reinventing the food and water supply chain, medicine, healthcare, diagnostics, agriculture, and biomaterial industries. To date, 116 companies have graduated from the program, with a combined current valuation of over $2B.

IndieBio is a member of SOSV a $700M global fund focused on lasting impact.

Follow on www.twitter.com/indbio

Peter Brannen, Author of The Ends of the World & Science Journalist featured on "Designing Science" podcast with Arvind Gupta, Founder and Managing director of IndieBio.

IndieBio is a leading seed-stage life science accelerator program devoted to funding and building startups dedicated to solving humanity’s most pressing problems through biology.

We enable the best scientists to become entrepreneurs, and nurture the future leaders of movements and systemic change. Our technology focus is on reinventing the food and water supply chain, medicine, healthcare, diagnostics, agriculture, and biomaterial industries. To date, 116 companies have graduated from the program, with a combined current valuation of over $2B.

IndieBio is a member of SOSV a $700M global fund focused on lasting impact.

Follow on www.twitter.com/indbio

Jonathan Foley, Executive Director of Project Drawdown featured on "Designing Science" podcast with Arvind Gupta, Founder and Managing director of IndieBio.

IndieBio is a leading seed-stage life science accelerator program devoted to funding and building startups dedicated to solving humanity’s most pressing problems through biology.

We enable the best scientists to become entrepreneurs, and nurture the future leaders of movements and systemic change. Our technology focus is on reinventing the food and water supply chain, medicine, healthcare, diagnostics, agriculture, and biomaterial industries. To date, 116 companies have graduated from the program, with a combined current valuation of over $2B.

IndieBio is a member of SOSV a $700M global fund focused on lasting impact.

Follow on www.twitter.com/indbio